PNV 3.57% $2.43 polynovo limited

The Clinicians Speak, page-909

  1. 2,940 Posts.
    lightbulb Created with Sketch. 189
    If BARDA are looking for evidence to bring forward the closing of SOC trial for burns this paper could help given the range of patients
    and time covered in this paper.
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.